Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer

Histopathology

Volumn 24, Issue 2, 1994, Pages 131-138

  PYKE, C ^a   RALFKIAER E ^a   RONNE E ^a   HOYER HANSEN G ^a   KIRKEBY, L ^b   DANO K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b FREDERIKSBERG HOSPITAL   (Denmark)

Author keywords

colon adenocarcinoma; immunohistochemistry; urokinase; urokinase receptor

Indexed keywords

CELL RECEPTOR; PLASMINOGEN ACTIVATOR; PROUROKINASE; UROKINASE;

ARTICLE; CLINICAL ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL;

ADENOCARCINOMA; COLONIC NEOPLASMS; HUMAN; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; RECEPTORS, CELL SURFACE; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T;

EID: 0028357266     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.1994.tb01291.x     Document Type: Article

References (41)

1. Plasminogen activators, tissue degradation and cancer
2. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation
3. Heparanase and tumor metastasis
4. Urokinase‐type plasminogen activator. Proenzyme, plasma membrane binding site and inhibitors
5. The urokinase receptor. Involvement in cell surface proteolysis and cancer invasion
6. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase
7. Differentiation‐enhanced binding of the amino‐terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes
8. A 55,000‐60,000 Mr receptor protein for urokinase‐type plasminogen activator. Identification in human tumor cell lines and partial purification
9. The human receptor for urokinase plasminogen activator: N‐terminal amino acid sequence and glycosylation variants
10. Cellular receptor for urokinase plasminogen activator: carboxyl‐terminal processing and membrane anchoring by glycosylphosphatidylinositol
11. Cloning and expression of the receptor for human urokinase—plasminogen activator, a central molecule in cell‐surface plasmin‐dependent proteolysis
12. Assignment of the gene for urokinasetype plasminogen activator receptor (PLARU) to chromosome 19q13
13. Binding of single‐chain prourokinase to the urokinase receptor of human U937 cells
14. Plasminogen activation by receptor‐bound urokinase
15. Cell‐induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2‐terminal domain of the urokinase receptor
16. Urokinase‐type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas
17. Localization of urokinase‐type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans
18. A better cell line for making hybridomas secreting specific antibodies
19. Plasminogen activator inhibitor type 1 in Lewis lung carcinoma
20. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand‐binding domain
21. The receptor for urokinase‐type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria
22. The receptor for urokinase‐type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane upon stimulation of human neutrophils
23. The receptor for urokinase is present in tumor‐associated macrophages in ductal breast carcinoma
24. Meiotic maturation of mouse oocytes trigger the translation and polyadenylation of dormant tissue‐type plasminogen activator mRNA
25. The plasminogen activation system in human colon cancer. Messenger RNA for the inhibitor PAI‐1 is located in endothelial cells in the tumor stroma
26. Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours
27. Stromal expression of 72 kDa type‐IV collagenase (MMP‐2) and TIMP‐2 messenger RNAs in colorectal neoplasia
28. Messsenger RNA for two type IV collageneses is located in non‐malignant stromal cells in human colon cancer
29. Cytokines and proteases in invasive processes—molecular similarities between inflammation and cancer
30. The origin and function of tumor‐associated macrophages
31. Localization of messenger RNA for Mr72.000 and 92.000 type IV collagenases in human skin cancers by in situ hybridization
32. Differential protease expression by cutaneous squamous and basal cell carcinomas
33. Expression of the stromelysin‐3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review
34. Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor beta
35. Transforming growth factor‐beta is a strong and fast acting positive regulator of the level of type‐1 plasminogen activator inhibitor mRNA in WI‐38 human lung fibroblasts
36. Urokinase‐receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor β1 in human A549 lung carcinoma cells
37. Characterization of human endothelial cell urokinase‐type plasminogen activator receptor protein and messenger RNA
38. Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract
39. Distribution of urokinase‐type plasminogen activator immunoreactivity in the mouse